Wealthfront Advisers’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.6M | Sell |
337,182
-7,829
| -2% | -$1.82M | 0.16% | 58 |
|
|
2026
Q1 | $84.3M | Buy |
345,011
+17,469
| +5% | +$4.07M | 0.19% | 53 |
|
|
2025
Q4 | $67.8M | Buy |
327,542
+13,455
| +4% | +$2.66M | 0.15% | 57 |
|
|
2025
Q3 | $58.2M | Buy |
314,087
+27,625
| +10% | +$4.73M | 0.14% | 60 |
|
|
2025
Q2 | $43.8M | Buy |
286,462
+34,394
| +14% | +$5.29M | 0.11% | 65 |
|
|
2025
Q1 | $41.8M | Buy |
252,068
+93,127
| +59% | +$14.6M | 0.11% | 64 |
|
|
2024
Q4 | $23M | Buy |
158,941
+14,614
| +10% | +$2.26M | 0.07% | 87 |
|
|
2024
Q3 | $23.4M | Buy |
144,327
+22,202
| +18% | +$3.54M | 0.07% | 79 |
|
|
2024
Q2 | $17.8M | Sell |
122,125
-8,898
| -7% | -$1.32M | 0.06% | 91 |
|
|
2024
Q1 | $20.7M | Buy |
131,023
+9,013
| +7% | +$1.43M | 0.07% | 74 |
|
|
2023
Q4 | $19.1M | Sell |
122,010
-21,341
| -15% | -$3.27M | 0.07% | 73 |
|
|
2023
Q3 | $22.3M | Sell |
143,351
-22,440
| -14% | -$3.7M | 0.1% | 65 |
|
|
2023
Q2 | $27.4M | Sell |
165,791
-11,094
| -6% | -$1.79M | 0.12% | 58 |
|
|
2023
Q1 | $27.4M | Sell |
176,885
-70,240
| -28% | -$11.3M | 0.12% | 50 |
|
|
2022
Q4 | $43.7M | Buy |
247,125
+20,254
| +9% | +$3.5M | 0.21% | 32 |
|
|
2022
Q3 | $37.1M | Sell |
226,871
-14,111
| -6% | -$2.39M | 0.2% | 32 |
|
|
2022
Q2 | $42.8M | Buy |
240,982
+83,888
| +53% | +$14.9M | 0.22% | 30 |
|
|
2022
Q1 | $27.8M | Buy |
157,094
+8,882
| +6% | +$1.51M | 0.12% | 40 |
|
|
2021
Q4 | $25.4M | Buy |
148,212
+14,541
| +11% | +$2.38M | 0.11% | 41 |
|
|
2021
Q3 | $21.6M | Buy |
133,671
+5,203
| +4% | +$888K | 0.1% | 43 |
|
|
2021
Q2 | $21.2M | Buy |
128,468
+4,602
| +4% | +$762K | 0.1% | 37 |
|
|
2021
Q1 | $20.4M | Buy |
123,866
+11,579
| +10% | +$1.87M | 0.11% | 36 |
|
|
2020
Q4 | $17.7M | Buy |
112,287
+15,343
| +16% | +$2.26M | 0.11% | 38 |
|
|
2020
Q3 | $14.4M | Buy |
96,944
+3,492
| +4% | +$517K | 0.1% | 39 |
|
|
2020
Q2 | $13.1M | Buy |
93,452
+19,046
| +26% | +$2.78M | 0.1% | 39 |
|
|
2020
Q1 | $9.76M | Sell |
74,406
-17,435
| -19% | -$2.47M | 0.09% | 42 |
|
|
2019
Q4 | $13.4M | Buy |
91,841
+13,337
| +17% | +$1.81M | 0.1% | 36 |
|
|
2019
Q3 | $10.2M | Sell |
78,504
-9,674
| -11% | -$1.27M | 0.09% | 41 |
|
|
2019
Q2 | $12.3M | Sell |
88,178
-12,696
| -13% | -$1.76M | 0.11% | 36 |
|
|
2019
Q1 | $14.1M | Buy |
100,874
+15,615
| +18% | +$2.09M | 0.13% | 29 |
|
|
2018
Q4 | $11M | Buy |
+85,259
| New | +$11.9M | 0.12% | 36 |
|
Other funds holding JNJ
N
Wealthfront Advisers's JNJ Position: Q2 2026 in Review
Wealthfront Advisers reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, selling an estimated $1.82M and leaving 337,182 shares worth $85.6M. The position accounts for 0.16% of the portfolio, ranked #58.
Wealthfront Advisers first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 3,446 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Wealthfront Advisers held 337,182 shares of Johnson & Johnson worth $85.6M as of Q2 2026.
- Wealthfront Advisers sold 7,829 Johnson & Johnson shares in Q2 2026, an estimated $1.82M.
- Johnson & Johnson made up 0.16% of Wealthfront Advisers's portfolio in Q2 2026, its #58 holding.
- Wealthfront Advisers first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 3,446 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.